Establishment of inherent stability of pramipexole and development of validated stability indicating LC–UV and LC–MS method

Pramipexole belongs to a class of nonergot dopamine agonist recently approved for the treatment of early and advanced Parkinson's disease. A validated specific stability indicating reversed-phase liquid chromatographic method has been developed for the quantitative determination of pramipexole...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Shubhangi M., Khatal, Laxman D., Gabhe, Satish Y., Dhaneshwar, Sunil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760940/
https://www.ncbi.nlm.nih.gov/pubmed/29403804
http://dx.doi.org/10.1016/j.jpha.2012.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760940/
https://www.ncbi.nlm.nih.gov/pubmed/29403804
http://dx.doi.org/10.1016/j.jpha.2012.07.011

Ejemplares similares